Astellas Pharma Inc. (YPHA)
Market Open
3 Mar, 07:08
XFRA XFRA Primary €
12. 80
-0.2
-1.54%
€
21.03B Market Cap
152.62 P/E Ratio
148% Div Yield
0 Volume
0.14 Eps
€ 13
Previous Close Day Range
12.8 12.8
Year Range
7.5 13.8
Want to track YPHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
YPHA earnings report is expected in 51 days (23 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
YPHA Earnings Reports FAQ
What is the earnings per share (EPS) for YPHA?
The current EPS is 0.14.
What is the company's earnings growth rate?
Astellas Pharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-23, based on the YPHA's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Astellas Pharma Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for YPHA at this time, as Astellas Pharma Inc has no recent EPS data to calculate it.
